Sirtex
http://dbpedia.org/resource/Sirtex an entity of type: Thing
Sirtex Medical Limited is a medical device company, providing radioactive treatment for inoperable liver cancer called SIR-Spheres microspheres. Sirtex was established in 1997 in Australia and currently maintains offices and manufacturing facilities in the U.S., Australia, Germany and Singapore. Following an acquisition by China Grand Pharmaceutical and CDH Genetech, Sirtex de-listed from the Australian Securities Exchange (ASX:SRX) on Monday, September 24, 2018. The company is currently headed by Kevin R. Smith, who was appointed as CEO on October 16, 2019.
rdf:langString
rdf:langString
Sirtex
rdf:langString
Sirtex Medical Limited
rdf:langString
Sirtex Medical Limited
xsd:integer
8295990
xsd:integer
1111097413
xsd:integer
1997
rdf:langString
Woburn, MA
rdf:langString
Sirtex logo.jpg
xsd:integer
1000
rdf:langString
China Grand Pharmaceutical and Healthcare Holdings Ltd./CDH Genetech, Ltd.
rdf:langString
SIR-Spheres yttrium-90 resin microspheres
rdf:langString
Private
rdf:langString
Sirtex Medical Limited is a medical device company, providing radioactive treatment for inoperable liver cancer called SIR-Spheres microspheres. Sirtex was established in 1997 in Australia and currently maintains offices and manufacturing facilities in the U.S., Australia, Germany and Singapore. Following an acquisition by China Grand Pharmaceutical and CDH Genetech, Sirtex de-listed from the Australian Securities Exchange (ASX:SRX) on Monday, September 24, 2018. The company is currently headed by Kevin R. Smith, who was appointed as CEO on October 16, 2019.
xsd:nonNegativeInteger
13498
xsd:gYear
1997
xsd:nonNegativeInteger
1000